MARKET

CELU

CELU

Celularity Inc
NASDAQ
1.520
-0.150
-8.98%
Opening 15:45 05/12 EDT
OPEN
1.600
PREV CLOSE
1.670
HIGH
1.740
LOW
1.510
VOLUME
46.23K
TURNOVER
--
52 WEEK HIGH
5.22
52 WEEK LOW
1.001
MARKET CAP
36.40M
P/E (TTM)
-0.9999
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CELU last week (0505-0509)?
Weekly Report · 10h ago
Celularity reports FY results
Seeking Alpha · 3d ago
Celularity reports FY24 EPS ($2.64) vs. ($11.02) last year
TipRanks · 3d ago
*Celularity FY24 Rev $54.2M >CELU
Dow Jones · 3d ago
Press Release: Celularity Announces Full Year 2024 Operating and Financial Results
Dow Jones · 3d ago
Press Release: Celularity Announces Full Year -2-
Dow Jones · 3d ago
Celularity Announces Full Year 2024 Operating and Financial Results
Barchart · 3d ago
Based on the provided financial report articles, I generated the title for the article: "CEL-Immunome Therapeutics, Inc. (0001752828) Annual Report for the Fiscal Year Ended December 31, 2024" Please note that the title may not be exact, as the provided text does not contain a clear title. However, based on the content and format of the report, I inferred the title to be the above-mentioned one.
Press release · 3d ago
More
About CELU
More
Celularity Inc. is a regenerative and cellular medicine company. It is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs that target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. It develops, manufactures and commercializes advanced biomaterial products derived from structural tissue components of the postpartum placental tissues, including the umbilical cord. Its advanced biomaterials include Celularity Tendon Wrap, FUSE Bone Void Filler and Celularity Placental Matrix. Its advanced biomaterial products include Biovance, Interfyl and Rebound products. Its platform is Celularity IMPACT (Immuno-Modulatory Placental-derived Allogeneic Cell Therapy).
Recently
Symbol
Price
%Change

Webull offers Celularity Inc stock information, including NASDAQ: CELU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELU stock methods without spending real money on the virtual paper trading platform.